J R Ellis

Summary

Affiliation: University of Melbourne
Country: Australia

Publications

  1. doi Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[18F]fluoro-A-85380 PET study
    J R Ellis
    Department of Nuclear Medicine and Centre for PET, Austin Hospital, 145 Studley Road, Heidelberg, Victoria 3084, Australia
    Neurobiol Learn Mem 90:404-12. 2008
  2. doi Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET
    J R Ellis
    School of Psychology, Psychiatry, and Psychological Medicine, Monash University, Melbourne, Victoria, Australia
    Psychopharmacology (Berl) 202:79-91. 2009
  3. doi The relationship between nicotinic receptors and cognitive functioning in healthy aging: An in vivo positron emission tomography (PET) study with 2-[(18)F]fluoro-A-85380
    J R Ellis
    Monash University, Victoria, Australia
    Synapse 63:752-63. 2009
  4. ncbi Evidence for synergistic modulation of early information processing by nicotinic and muscarinic receptors in humans
    F F Erskine
    Neuropsychopharmacology Laboratory, Brain Sciences Institute, Swinburne University, Melbourne, Australia
    Hum Psychopharmacol 19:503-9. 2004

Collaborators

Detail Information

Publications4

  1. doi Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[18F]fluoro-A-85380 PET study
    J R Ellis
    Department of Nuclear Medicine and Centre for PET, Austin Hospital, 145 Studley Road, Heidelberg, Victoria 3084, Australia
    Neurobiol Learn Mem 90:404-12. 2008
    ..It is possible that while the clinical 2-FA PET method described here may be insensitive in detecting changes in early AD, such changes may be detected in more advanced stages of the illness...
  2. doi Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET
    J R Ellis
    School of Psychology, Psychiatry, and Psychological Medicine, Monash University, Melbourne, Victoria, Australia
    Psychopharmacology (Berl) 202:79-91. 2009
    ..e., galantamine) that potentiate cholinergic neurotransmission improve cognitive function in Alzheimer's disease (AD); however, the relationship between these effects and associated changes in nAChRs are yet to be established in vivo...
  3. doi The relationship between nicotinic receptors and cognitive functioning in healthy aging: An in vivo positron emission tomography (PET) study with 2-[(18)F]fluoro-A-85380
    J R Ellis
    Monash University, Victoria, Australia
    Synapse 63:752-63. 2009
    ..However, this approach may be appropriate for use in pathologies considered to undergo extensive nAChR loss such as Alzheimer's disease and Parkinson's disease...
  4. ncbi Evidence for synergistic modulation of early information processing by nicotinic and muscarinic receptors in humans
    F F Erskine
    Neuropsychopharmacology Laboratory, Brain Sciences Institute, Swinburne University, Melbourne, Australia
    Hum Psychopharmacol 19:503-9. 2004
    ..These findings suggest that functional abnormalities in both nicotinic and muscarinic systems may underlie deficits in early visual information processing seen in disorders such as Alzheimer's disease and schizophrenia...